What does CUSIP 29089Q105 represent in this 13F holders report?

CUSIP 29089Q105 is the security identifier for EBS - Emergent BioSolutions Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held EBS - Emergent BioSolutions Inc. - Common Stock in Q4 2018?

293 institutional investors reported EBS - Emergent BioSolutions Inc. - Common Stock for Q4 2018. Use the holders table for investor-level position and value details.

Emergent BioSolutions Inc. - Common Stock (EBS)

CUSIP: 29089Q105

Q4 2018 13F Holders as of 31 Dec 2018

Type / Class: Equity / Common Stock
Shares outstanding: 51,688,294
Total 13F shares: 43,083,866
Share change: +620,872
Total reported value: $2,553,149,934
Put/Call ratio: 48%
Price per share: $59.28
Number of holders: 293
Value change: +$34,101,099
Number of buys: 139
Number of sells: 132

Quarterly Holders Quick Answers

What is CUSIP 29089Q105?
CUSIP 29089Q105 identifies EBS - Emergent BioSolutions Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2019
Previous quarter: Q3 2018

Recent filing periods for CUSIP 29089Q105:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of EBS - Emergent BioSolutions Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
BlackRock Finance, Inc.	13F	Company	12%	6,350,905	$418,078,000	—	30 Sep 2018	13F
VANGUARD GROUP INC	13F	Company	8.9%	4,603,209	$303,029,000	—	30 Sep 2018	13F
STATE STREET CORP	13F	Company	3.7%	1,893,306	$124,639,000	—	30 Sep 2018	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	3.6%	1,871,311	$123,188,000	—	30 Sep 2018	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	3.4%	1,747,821	$115,059,000	—	30 Sep 2018	13F
ACADIAN ASSET MANAGEMENT LLC	13F	Company	2.5%	1,267,510	$83,442,000	—	30 Sep 2018	13F
Invesco Ltd.	13F	Company	2.2%	1,129,433	$74,351,000	—	30 Sep 2018	13F
RICE HALL JAMES & ASSOCIATES, LLC	13F	Company	2.2%	1,115,875	$73,458,000	—	30 Sep 2018	13F
SNYDER CAPITAL MANAGEMENT L P	13F	Company	2.2%	1,113,198	$73,282,000	—	30 Sep 2018	13F
Aberdeen Group plc	13F	Company	2.1%	1,097,447	$72,245,000	—	30 Sep 2018	13F
GOLDMAN SACHS GROUP INC	13F	Company	2%	1,029,575	$67,776,000	—	30 Sep 2018	13F
NORTHERN TRUST CORP	13F	Company	1.9%	974,036	$64,121,000	—	30 Sep 2018	13F
ROYAL BANK OF CANADA	13F	Company	1.8%	947,861	$62,398,000	—	30 Sep 2018	13F
Bank of New York Mellon Corp	13F	Company	1.6%	851,840	$56,077,000	—	30 Sep 2018	13F
NORGES BANK	13F	Company	1.6%	836,399	$55,060,000	—	30 Sep 2018	13F
GLENMEDE TRUST CO NA	13F	Company	1.5%	797,408	$52,493,000	—	30 Sep 2018	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	1.4%	730,762	$48,106,000	—	30 Sep 2018	13F
Man Group plc	13F	Company	1.1%	580,779	$38,232,000	—	30 Sep 2018	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.91%	467,830	$30,796,000	—	30 Sep 2018	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.89%	459,384	$30,242,000	—	30 Sep 2018	13F
FMR LLC	13F	Company	0.81%	419,175	$27,594,000	—	30 Sep 2018	13F
PRINCIPAL FINANCIAL GROUP INC	13F	Company	0.74%	383,624	$25,254,000	—	30 Sep 2018	13F
Matarin Capital Management, LLC	13F	Company	0.72%	372,980	$24,553,274	—	30 Sep 2018	13F
AMERIPRISE FINANCIAL INC	13F	Company	0.7%	363,698	$23,942,000	—	30 Sep 2018	13F
OppenheimerFunds, Inc.	13F	Company	0.69%	354,560	$23,340,000	—	30 Sep 2018	13F
PRUDENTIAL FINANCIAL INC	13F	Company	0.65%	336,554	$22,156,000	—	30 Sep 2018	13F
Neuberger Berman Group LLC	13F	Company	0.65%	335,170	$22,064,000	—	30 Sep 2018	13F
PEREGRINE CAPITAL MANAGEMENT LLC	13F	Company	0.6%	310,213	$20,421,000	—	30 Sep 2018	13F
DEUTSCHE BANK AG\	13F	Company	0.6%	308,173	$20,287,000	—	30 Sep 2018	13F
Fisher Asset Management, LLC	13F	Company	0.58%	300,475	$19,780,000	—	30 Sep 2018	13F
AQR CAPITAL MANAGEMENT LLC	13F	Company	0.52%	269,746	$17,757,000	—	30 Sep 2018	13F
PARAMETRIC PORTFOLIO ASSOCIATES LLC	13F	Company	0.52%	266,670	$17,555,000	—	30 Sep 2018	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.49%	254,621	$16,763,000	—	30 Sep 2018	13F
MORGAN STANLEY	13F	Company	0.49%	254,168	$16,731,000	—	30 Sep 2018	13F
FEDERATED HERMES, INC.	13F	Company	0.42%	219,460	$14,446,000	—	30 Sep 2018	13F
NEW AMSTERDAM PARTNERS LLC/NY	13F	Company	0.41%	210,636	$13,866,000	—	30 Sep 2018	13F
TIAA CREF INVESTMENT MANAGEMENT LLC	13F	Company	0.4%	208,153	$13,703,000	—	30 Sep 2018	13F
FULLER & THALER ASSET MANAGEMENT, INC.	13F	Company	0.4%	207,155	$13,637,000	—	30 Sep 2018	13F
Phocas Financial Corp.	13F	Company	0.4%	207,027	$13,629,000	—	30 Sep 2018	13F
PANAGORA ASSET MANAGEMENT INC	13F	Company	0.38%	194,422	$12,799,000	—	30 Sep 2018	13F
Russell Investments Group, Ltd.	13F	Company	0.36%	186,116	$12,234,000	—	30 Sep 2018	13F
KENNEDY CAPITAL MANAGEMENT LLC	13F	Company	0.3%	152,595	$10,045,000	—	30 Sep 2018	13F
ClariVest Asset Management LLC	13F	Company	0.29%	147,663	$9,719,000	—	30 Sep 2018	13F
PUTNAM INVESTMENTS LLC	13F	Company	0.28%	147,110	$9,684,000	—	30 Sep 2018	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.28%	146,984	$9,676,000	—	30 Sep 2018	13F
EAGLE ASSET MANAGEMENT INC	13F	Company	0.28%	146,360	$9,634,000	—	30 Sep 2018	13F
MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC	13F	Company	0.28%	145,787	$9,597,000	—	30 Sep 2018	13F
NORDEA INVESTMENT MANAGEMENT AB	13F	Company	0.28%	144,566	$9,516,000	—	30 Sep 2018	13F
GUGGENHEIM CAPITAL LLC	13F	Company	0.26%	136,871	$9,010,000	—	30 Sep 2018	13F
Hillcrest Asset Management LLC	13F	Company	0.26%	135,606	$8,927,000	—	30 Sep 2018	13F

Institutional Holders of Emergent BioSolutions Inc. - Common Stock (EBS) as of Q4 2018

As of 31 Dec 2018, Emergent BioSolutions Inc. - Common Stock (EBS) was held by 293 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 43,083,866 shares. The largest 10 holders included BlackRock Inc., Vanguard Group Inc, STATE STREET CORP, DIMENSIONAL FUND ADVISORS LP, RENAISSANCE TECHNOLOGIES LLC, RICE HALL JAMES & ASSOCIATES, LLC, Neuberger Berman Group LLC, SNYDER CAPITAL MANAGEMENT L P, ACADIAN ASSET MANAGEMENT LLC, and Invesco Ltd.. This page lists 293 institutional shareholders reporting positions in this security for the Q4 2018 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2018 vs Q3 2018 Across Filers

Q3 2018 holders

269

Q4 2018 holders

293

Holder diff

Investor	Q3 2018 Shares	Q4 2018 Shares	Share Diff	Share Chg %	Q3 2018 Value $	Q4 2018 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.